Harbin Medisan Pharmaceutical Co Ltd (002900) — Capital Reinvestment Ratio
Harbin Medisan Pharmaceutical Co Ltd (002900) has a Capital Reinvestment Ratio of 0.79x as of March 2025, meaning it reinvests 1% of its operating cash flow (CN¥86.31 Million) in capital expenditures (CN¥68.40 Million). See how leveraged is Harbin Medisan Pharmaceutical Co Ltd's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Harbin Medisan Pharmaceutical Co Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Harbin Medisan Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Check Harbin Medisan Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Harbin Medisan Pharmaceutical Co Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Harbin Medisan Pharmaceutical Co Ltd from 2012 to 2024. For live market cap and broader valuation context, see how much is Harbin Medisan Pharmaceutical Co Ltd worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 11.28x | CN¥30.69 Million | CN¥346.21 Million | ▲ +34.4% |
| 2023 | 8.39x | CN¥35.69 Million | CN¥299.58 Million | ▲ +1260.6% |
| 2022 | 0.62x | CN¥144.64 Million | CN¥89.22 Million | ▼ -0.6% |
| 2019 | 0.62x | CN¥320.14 Million | CN¥198.63 Million | ▲ +131.4% |
| 2018 | 0.27x | CN¥292.46 Million | CN¥78.41 Million | ▼ -42.9% |
| 2017 | 0.47x | CN¥223.46 Million | CN¥104.93 Million | ▲ +15.6% |
| 2016 | 0.41x | CN¥231.18 Million | CN¥93.88 Million | ▼ -42.4% |
| 2015 | 0.71x | CN¥200.85 Million | CN¥141.72 Million | ▼ -43.7% |
| 2014 | 1.25x | CN¥116.31 Million | CN¥145.81 Million | ▲ +35.9% |
| 2013 | 0.92x | CN¥167.10 Million | CN¥154.13 Million | ▲ +24.9% |
| 2012 | 0.74x | CN¥123.22 Million | CN¥91.01 Million | — |